Innovation Spotlight: The Future of Business

With a fresh $4.05M in funding, LoopX is deploying 'All-Condition Intelligence' to make mining safer and more productive where traditional tech fails.

As AI-powered 'Agentic Fraud' escalates, Incode's new solution verifies identity by matching a selfie against DMV records, promising a new era of digital trust.

Healis Therapeutics gets FDA nod for Tyemvers, a botulinum toxin therapy for depression. Can a drug that paralyzes frown muscles disrupt mental healthcare?

E*TRADE's latest data shows a pivot to Materials and Industrials, signaling a bet on long-term growth, while caution in Financials reveals inflation anxiety.

As Asia scales its AI ambitions, Tech Week Singapore 2026 addresses the crucial foundation: infrastructure. See how the region is building for this new era.

Amidst banking boycotts, Credova built a fintech empire for firearms. We explore how its 'uncancellable' ecosystem is reshaping the gun rights debate.

Toronto's Titan One agency achieves rigorous B Corp status, signaling a major shift. This isn't just about ethics; it's a new playbook for B2B growth.

With a fresh $550M, Antora Energy is scaling its thermal batteries to solve America's energy crunch, promising cheap, clean power for industry and data centers.

As AI reshapes the threat landscape, VC firm Costanoa brings in ex-Uber and Meta CSO Joe Sullivan. A look at why operational expertise is the new currency in cybersecurity investing.

Amidst high interest rates and a 5.6% drop in new home sales, MPCs are up 3%. This isn't just a trend; it's a fundamental shift in homebuyer priorities.

With a leaner portfolio and a sharper focus on AI, Lightspeed's latest earnings reveal a company reborn, posting strong growth and a clear path to profit.

AB2 Bio's partnership with Nippon Shinyaku for Tadekinig alfa signals a new era for ultra-rare pediatric care and highlights a savvy biotech financing strategy.

Horizon Media is betting its future not on AI automation, but on human-AI synergy, starting with its interns. A look inside their AI Fluency Experience.

After Casago's $130M acquisition of Vacasa, a unique challenge emerged. A niche lender developed a new playbook to fund the deal's aftermath.

The Japanese company famed for coffee gear relaunches its glass jewelry in the U.S., weaving a story of female empowerment and sustainable craft.

MedLink Global's AI tool, now qualified by Mayo Clinic, promises to tackle clinician burnout and transform psychiatry with structured, data-driven insights.

A new biotech, CORE Biomedicine, armed with Eisai's preclinical assets and a $21M Series A, aims to upend oncology by targeting cancer's 'lineage' identity.

Everseen's acquisition of Viztel merges checkout security with full-store analytics, creating a single AI platform poised to redefine retail operations.

Guardian Capital's new fund deploys AI to analyze the AI sector, offering a dynamic alternative to static ETFs for investors chasing the tech megatrend.

Activewear brand WISKII's Riviera pop-up isn't just retail; it's a strategic playbook for global expansion using experiential luxury and wellness.